Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) was the recipient of a significant increase in short interest in the month of July. As of July 15th, there was short interest totalling 3,630,000 shares, an increase of 9.0% from the June 30th total of 3,330,000 shares. Approximately 15.0% of the shares of the company […]
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) – Investment analysts at William Blair issued their Q2 2023 earnings estimates for shares of Arcturus Therapeutics in a research note issued to investors on Monday, July 24th. William Blair analyst M. Minter anticipates that the biotechnology company will post earnings per share of $0.69 for the […]
Arcturus to present at the Canaccord Genuity 43rd Annual Growth Conference, August 9, 2023SAN DIEGO (BUSINESS WIRE) $ARCT #ClinicalTrial Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infecti.
Insider Selling: Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) Insider Sells 6,968 Shares of Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Pad Chivukula Sells 25,000 Shares of Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.